New drug may ease ENT symptoms in rare autoimmune disease
Disease control
Not yet recruiting
This study tests whether adding TAVNEOS to standard treatment helps control ear, nose, and throat symptoms in people with granulomatosis with polyangiitis (GPA), a rare autoimmune disease. About 30 adults with active ENT disease will receive either TAVNEOS or a placebo for 52 wee…
Phase: PHASE2, PHASE3 • Sponsor: Robert Spiera, MD • Aim: Disease control
Last updated May 12, 2026 13:42 UTC